Capricor Therapeutics, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $20.9M | $105.4M | $287.8M | $19.5M | $23.2M | $28.8M | $11.3M | $68.4M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $242.1M | $283.1M | $322.9M | $101.0M | $124.1M | $146.3M | $163.4M | $85.8M |
| Property, Plant & Equipment | $36.3M | $28.5M | $18.3M | $11.1M | $8.0M | $6.1M | $5.6M | $5.3M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $368.7M | $326.3M | $355.9M | $126.4M | $133.6M | $153.8M | $170.5M | $93.0M |
| Liabilities | ||||||||
| Accounts Payable | $3.1M | $3.9M | $1.7M | $2.7M | $4.8M | $5.3M | $3.3M | — |
| Total Current Liabilities | $33.0M | $33.6M | $35.8M | $28.1M | $28.4M | $22.3M | $21.0M | $20.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $122.5M | $47.6M | $50.2M | $42.6M | $28.6M | $26.1M | $25.0M | $24.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-379.6M | $-338.8M | $-304.9M | $-274.7M | $-250.1M | $-224.2M | $-199.8M | $-192.7M |
| Total Stockholders' Equity | $246.2M | $278.7M | $305.8M | $83.9M | $105.0M | $127.6M | $145.5M | $68.3M |